Undersøgelsen viste gavnlig effekt af memantinbehandlingen sammenlignet med placebo over en behandlingsperiode på 6 måneder (” observed cases analysis ” for the Clinician´s interview based impression of change (CIBIC- plus): p=0, 025; Alzheimer´s disease cooperative study – activities of daily living (ADCS- ADLsev): p=0, 003; Severe impairment battery (SIB): p=0, 002).
Lo studio ha dimostrato l’ efficacia del trattamento con memantina nei confronti del placebo a 6 mesi (analisi dei casi osservati Clinician’ s Interview based impression of change (CIBIC-plus): p=0,025; Alzheimer’ s Disease Cooperative Study – Activities of Daily Living (ADCS-ADLsev): p=0,003; Severe Impairment Battery (SIB): p=0,002).